Get ready to dive deep into the world of Health Technology and Digital Health! Join us for a captivating discussion featuring accomplished HealthTech executives and venture capital experts. In this unique session, you’ll gain insights into cutting-edge products, tackle industry challenges, and delve into what makes Health Technology startups attractive to investors. Discover the trends shaping the future of Health Tech and Digital Health in 2024, and learn firsthand how to secure vital capital to fuel your innovations on a global scale. Don’t miss out on this exclusive opportunity to engage with industry leaders, all while savoring Bavarian delicacies. It’s a combined session that promises to be both informative and delicious!
Who’s in the Room?
Rachel Robinson (Moderator) – Chief Operating Officer, Massachusetts Medical Device Industry Council (MassMEDIC)
A high-energy, connection-driven, non-profit executive, with a background in life sciences, technology and robotics engineering, Rachel Robinson is the Chief Operating Officer of MassMEDIC. As President of MassMEDIC IGNITE she has helped early stage startups raise more than $150M in the past two years. Their goal, and hers, is to drastically improve how medicine is practiced and challenge the standard of care.
Marc Feilerman – Managing Partner, German Entrepreneurship, Global Healthtech Life Sciences
Marc Filerman is Managing Partner at German Entrepreneurship, an organization accelerating market entry and international growth of promising German and European startups, where he leads the Global Healthtech Life Sciences Competence Center. He has over 30 years experience in healthtech commercialization, marketing, and sales. Marc co-founded a molecular imaging startup, was Chief Commercial Officer at a hometech venture, and has held multiple corporate leadership positions including VP of Global Marketing at iCAD, and Group Director of Marketing at Smith & Nephew. He holds MS and BS degrees from MIT and started his career at HP as a design engineer.
Charlie Cameron – Investor, Global Capital Connector, Cofounder / Managing Director Hub Investment Management Group
Charlie has over 20 years of management consulting, marketing and investing experience in more than 30 countries. His experience ranges from working on strategy with Fortune 500 companies to mentoring emerging technology companies to venture investing. He works with entrepreneurs, investors and family offices in Europe, the US and Canada. He served as SVP of Business Development at Cooley LLP, a national law firm with a broad, technology-oriented client base. Charlie has built a global network of entrepreneurs, VCs, angel groups, and service providers. Charlie has an MBA from MIT, an MPH from Harvard University, and a BA, Economics–honors, Phi Beta Kappa, from the University of Massachusetts.
Dr. Mridul Agrawal – Managing Director & Co-Founder at iuvando Health | Physician, Scientist and Healthcare Entrepreneur enabling access to clinical trials for cancer patients
Dr. Agrawal is a physician, scientist, and healthcare entrepreneur dedicated to advancing the care for cancer patients. He is President and co-founder of iuvando Health, a Germany-based, innovative digital health and precision oncology company, that enables patients with cancer to find and access life-saving treatments within clinical trials.
Prior, Dr. Agrawal was a research fellow at Dana-Farber Cancer Institute, Harvard Medical School, and the Broad Institute of MIT and Harvard with a focus on blood cancer. Dr. Agrawal studied medicine at Johns Hopkins University School of Medicine (Baltimore), University of Zurich, and Heidelberg University, where he graduated with a doctorate degree. He also obtained a master’s degree in Health Economics from Heidelberg University.
Dr. Agrawal was a scholar of the German Academic Scholarship Foundation (Studienstiftung des deutschen Volkes). He has been honored with multiple highly prestigious national and international awards both in his role as a physician-scientist and entrepreneur.
Dr.Joerg Traub – Head of Health, Bayern Innovativ GmbH, Community for Innovation and Knowledge Transfer;Managing Director of Forum Medtech Pharma, Europe’s Largest Network of the Healthcare and Medical Technology Industry
Joerg has more than 15 years of professional experience in the healthcare and medical technology industry. As an entrepreneur, he has accompanied several innovations from science through clinical validation to the market. Joerg holds a doctorate in computer science.
Since 2020 Joerg heads the Health specialization at Bayern Innovativ in Erlangen Germany and is the Managing director of Forum MedTech Pharma, Europes’ largest network of the healthcare and medical technology industry. He founded SurgicEye GmbH, a spin-off from the Technical University of Munich
In 2008, he founded and ran SurgicEye GmbH, a spin-off from the Technical University of Munich and an international medical technology manufacturer in the field of nuclear medical therapy procedures. Most recently, he worked at iSYS Medizintechnik GmbH in the field of intelligent robotic solutions for image-guided therapy.